Biohaven Pharmaceutical Holding Company Ltd (NYSE:BHVN)
| 103.54 Delayed Data As of Dec 03 |  -5.75 / -5.26%Today’s Change | 62.57 Today|||52-Week Range 151.51 | +20.80% Year-to-Date |
Latest BHVN News | Press Releases
No recent news for Biohaven Pharmaceutical Holding Company Ltd.
Today’s Trading
| Previous close | 109.29 |
| Today’s open | 108.77 |
| Day’s range | 102.15 - 110.35 |
| Volume | 792,455 |
| Average volume (3 months) | 453,976 |
| Market cap | $7.2B |
Data as of 4:00pm ET, 12/03/2021
Growth & Valuation
| Earnings growth (last year) | -19.72% |
| Earnings growth (this year) | +16.79% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | 79.12 |
| Price/Book | -- |
Financials
| Next reporting date | March 2, 2022 |
| EPS forecast (this quarter) | -$2.07 |
| Annual revenue (last year) | $63.6M |
| Annual profit (last year) | -$766.8M |
| Net profit margin | -1,205.14% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters New Haven, Connecticut |
Forecasts
